Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ALEMBIC PHARMACEUTICALS LTD.

NSE : APLLTDBSE : 533573ISIN CODE : INE901L01018Industry : Pharmaceuticals & DrugsHouse : Alembic

BSE655.95-20.3 (-3 %)

PREV CLOSE ( ) 676.25

OPEN PRICE ( ) 671.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3392

TODAY'S LOW / HIGH ( )650.40 671.50

52 WK LOW / HIGH ( )635.3 1107.8

NSE656.20-20.85 (-3.08 %)

PREV CLOSE( ) 677.05

OPEN PRICE ( ) 666.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 60922

TODAY'S LOW / HIGH( ) 650.00 673.55

52 WK LOW / HIGH ( )635.8 1107.9

Quarters

Select year

( in Million)

Particulars

Dec 2025

Sep 2025

Jun 2025

Mar 2025

Audited / UnAudited

UnAudited

Net Sales

18763.1

19101.5

17107.2

17696.4

Total Expenditure

15828.1

15944.6

14293.8

14977.1

PBIDT (Excl OI)

2935

3156.9

2813.4

2719.3

Other Income

155

69.1

141.9

Operating Profit

3090

3226

2878.4

2861.2

Interest

233.1

242.3

235.2

245.2

Exceptional Items

-422.3

PBDT

2434.6

2983.7

2643.2

2616

Depreciation

801.2

760.7

737.7

689.9

Profit Before Tax

1633.4

2223

1905.5

1926.1

Tax

295.5

400.1

364.7

353.2

Provisions and contingencies

Profit After Tax

1337.9

1822.9

1540.8

1572.9

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

1337.9

1822.9

1540.8

1572.9

Minority Interest

10.2

7.5

2.6

Shares of Associates

-18.4

14.2

-4.5

-6.6

Other related items

Misc. Expenses Written off

Consolidated Net Profit

1329.7

1847.1

1543.8

1568.9

Equity Capital

393.1

Face Value (IN RS)

Reserves

Calculated EPS

6.76

9.39

7.85

7.98

Calculated EPS (Annualised)

27.06

37.59

31.41

31.92

No of Public Share Holdings

59481311

59607869

59616534

% of Public Share Holdings

30.26

30.33

PBIDTM% (Excl OI)

15.64

16.52

16.44

15.36

PBIDTM%

16.46

16.88

16.82

16.16

PBDTM%

12.97

15.62

15.45

14.78

PBTM%

8.70

11.63

11.13

10.88

PATM%

7.13

9.54

9.00

8.88

Notes

Risk Disclosures on Derivatives

Quarterly Results

ALEMBIC PHARMACEUTICALS LTD.